- Clorox (CLX) is a leading consumer products company with a variety of strong brands.
- Average four-year revenue growth: 5%
- Average four-year earnings growth: 8%
- Average four-year cash flow growth: 12%
- Current dividend yield: 3.50%
- Dividend growth: 13%
- The balance sheet is a big weak spot, with liabilities almost matching total assets.
- Taking into account the strong company performance and their weak balance sheet, I find the current P/E of a bit over 13 to be fair. I feel that long-term risk-adjusted returns of an investment in this stock are likely to be reasonable.
click to enlarge
Clorox (NYSE: CLX) is a leading consumer products company. It was founded in 1913 and now has over 8000 employees. At one point during the middle of the 20th century, it was purchased by Procter and Gamble (PG), but the corporation was forced to sell Clorox due to fears that it would lead to a lack of competition.
|Segment||Net Sales Percentage|
Total 2010 revenue was $5.534 billion. Each of these categories includes a variety of strong brands, and some of them are listed below.
Clorox is a dividend aristocrat with a strong history of dividend growth. Calculations for the following chart are based on the calendar year rather than the fiscal year. The current dividend yield is 3.5% with a payout ratio of around 45%.
Clorox has grown its dividend by an average of 13% over the last five years. The most recent quarterly dividend raise was from $0.50 to $0.55, which is a 10% raise.
The balance sheet is an unattractive aspect of Clorox, because their total liabilities nearly equal their total assets. The balance sheet is among the worst in the industry. The total debt/equity ratio is extremely high, because the shareholder equity is nearly zero. Furthermore, goodwill and intangible assets greatly exceed the tiny amount of shareholder equity.
The interest coverage ratio is approximately 7.5, which means Clorox is safely covering its debt. Still, this is a lower value than I’d like to see in a long-term investment.
In the latest annual report, Clorox identified four “megatrends” that it uses to evaluate growth opportunities. These megatrends are:
- health and wellness
Clorox has been unleashing and acquiring several natural products, in line with the health and wellness and sustainability megatrends. These brands, like Burt’s Bees and Greenworks, are riding on consumer’s desires to use more natural products that have less harsh chemicals, avoid animal testing, and meet various requirements. Both of these brands have been successful and Clorox is aggressively advertising and promoting them.
The company has been attempting to increase its relevance among Hispanics, which represent a quickly growing portion of the U.S. population. Clorox also has operations around the world, developing products relevant to specific regions.
Some brands can blend several megatrends. Brita water filters, for example, helps consumers save money by eliminating water bottles, and this also has an appeal among those conscious about conservation of natural resources.
The company has been gradually increasing revenue, volume, earnings, cash flow, advertising, research and development, and of course, the dividend. This appears, in almost all ways, to be a strong, steady march towards continued long-term growth and profitability. The company has a portfolio of brands appealing to a wide audience, and I agree with their concepts of megatrends and feel that they have aligned the company with those trends very well.
Clorox faces risks of high commodity costs, and the industry it operates in is extremely competitive. Clorox’s highly leveraged position gives it more risk than industry peers. Due to its international presence there is also currency risk.
In conclusion, I think Clorox is a great company with an excellent dividend history. Unfortunately, Clorox’s balance sheet leaves a lot to be desired, and at this valuation, I think better opportunities exist. Still, I doubt that investors looking back from well into the future would be disappointed if they were to invest today, so it’s not necessarily a bad investment. The dividend growth rate coupled with the current dividend yield is quite impressive. The market capitalization of less than $9 billion means it's large enough to have pricing power, international exposure, and financial safety, and yet small enough to have years and years of impressive growth if it’s managed well.
Full Disclosure: As of this writing, I have no position in CLX, and I own shares of PG. You can see my full list of individual holdings here.